194 related articles for article (PubMed ID: 16623554)
21. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J
J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276
[TBL] [Abstract][Full Text] [Related]
23. Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.
Tomita K; Oishi S; Ohno H; Peiper SC; Fujii N
J Med Chem; 2008 Dec; 51(23):7645-9. PubMed ID: 19007202
[TBL] [Abstract][Full Text] [Related]
24. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
[TBL] [Abstract][Full Text] [Related]
25. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography.
Disa J; Floyd LE; Edwards RM; Douglas SA; Aiyar NV
Peptides; 2006 Jun; 27(6):1532-7. PubMed ID: 16290260
[TBL] [Abstract][Full Text] [Related]
27. Another ligand fishing for G protein-coupled receptor 14. Discovery of urotensin II-related peptide in the rat brain.
Sugo T; Mori M
Peptides; 2008 May; 29(5):809-12. PubMed ID: 17628210
[TBL] [Abstract][Full Text] [Related]
28. Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
Jin J; An M; Sapienza A; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Salyers KL; Knight SD; Keenan RM; Rivero RA; Dhanak D; Douglas SA
Bioorg Med Chem Lett; 2008 Jul; 18(14):3950-4. PubMed ID: 18573659
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and conformational investigation of cyclic dipeptides: 7-membered rings containing alpha- and beta-amino acids.
Müller-Hartwieg JC; Akyel KG; Zimmermann J
J Pept Sci; 2003 Mar; 9(3):187-99. PubMed ID: 12675501
[TBL] [Abstract][Full Text] [Related]
30. Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors.
Behm DJ; Herold CL; Camarda V; Aiyar NV; Douglas SA
Eur J Pharmacol; 2004 May; 492(2-3):113-6. PubMed ID: 15178353
[TBL] [Abstract][Full Text] [Related]
31. Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model.
Kinney WA; Almond HR; Qi J; Smith CE; Santulli RJ; de Garavilla L; Andrade-Gordon P; Cho DS; Everson AM; Feinstein MA; Leung PA; Maryanoff BE
Angew Chem Int Ed Engl; 2002 Aug; 41(16):2940-4. PubMed ID: 12203418
[No Abstract] [Full Text] [Related]
32. Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor.
Batuwangala M; Camarda V; McDonald J; Marzola E; Lambert DG; Ng LL; Calo' G; Regoli D; Trapella C; Guerrini R; Salvadori S
Peptides; 2009 Jun; 30(6):1130-6. PubMed ID: 19463746
[TBL] [Abstract][Full Text] [Related]
33. Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II.
Boivin S; Ségalas-Milazzo I; Guilhaudis L; Oulyadi H; Fournier A; Davoust D
Peptides; 2008 May; 29(5):700-10. PubMed ID: 18423797
[TBL] [Abstract][Full Text] [Related]
34. [Development of therapeutic agents related to urotensin II].
Mori M
Nihon Rinsho; 2004 Sep; 62 Suppl 9():741-4. PubMed ID: 15506486
[No Abstract] [Full Text] [Related]
35. Prediction of structure of G-protein coupled receptors and of bound ligands, with applications for drug design.
Li Y; Goddard WA
Pac Symp Biocomput; 2008; ():344-53. PubMed ID: 18229698
[TBL] [Abstract][Full Text] [Related]
36. Refinement of the pharmacophore of an agonist ligand of the secretin receptor using conformationally constrained cyclic hexapeptides.
Dong M; Narang P; Pinon DI; Bordner AJ; Miller LJ
Peptides; 2010 Jun; 31(6):1094-8. PubMed ID: 20214947
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationships of urotensin II and URP.
Leprince J; Chatenet D; Dubessy C; Fournier A; Pfeiffer B; Scalbert E; Renard P; Pacaud P; Oulyadi H; Ségalas-Milazzo I; Guilhaudis L; Davoust D; Tonon MC; Vaudry H
Peptides; 2008 May; 29(5):658-73. PubMed ID: 17931747
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and conformational studies of dipeptides constrained by disubstituted 3-(aminoethoxy)propionic acid linkers.
Reddy DS; Vander Velde D; Aubé J
J Org Chem; 2004 Mar; 69(5):1716-9. PubMed ID: 14987032
[TBL] [Abstract][Full Text] [Related]
39. Polydiscamides B-D from a marine sponge Ircinia sp. as potent human sensory neuron-specific G protein coupled receptor agonists.
Feng Y; Carroll AR; Pass DM; Archbold JK; Avery VM; Quinn RJ
J Nat Prod; 2008 Jan; 71(1):8-11. PubMed ID: 18163586
[TBL] [Abstract][Full Text] [Related]
40. Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.
Holleran BJ; Domazet I; Beaulieu ME; Yan LP; Guillemette G; Lavigne P; Escher E; Leduc R
Biochem Pharmacol; 2009 Apr; 77(8):1374-82. PubMed ID: 19426676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
